M. Grimm Et Al. , "Treatment of high-grade non-muscle invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations: Results of the phase III clinical trial (NIMBUS)," Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO) , vol.38, San-Francisco, Costa Rica, 2020
Grimm, M. Et Al. 2020. Treatment of high-grade non-muscle invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations: Results of the phase III clinical trial (NIMBUS). Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO) , (San-Francisco, Costa Rica).
Grimm, M., van der Heijden, T., Colombel, M., Martinez Pineiro, L., Muilwijk, T., Babjuk, M., ... Turkeri, L.(2020). Treatment of high-grade non-muscle invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations: Results of the phase III clinical trial (NIMBUS) . Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San-Francisco, Costa Rica
Grimm, Marc-Oliver Et Al. "Treatment of high-grade non-muscle invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations: Results of the phase III clinical trial (NIMBUS)," Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San-Francisco, Costa Rica, 2020
Grimm, Marc-Oliver Et Al. "Treatment of high-grade non-muscle invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations: Results of the phase III clinical trial (NIMBUS)." Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO) , San-Francisco, Costa Rica, 2020
Grimm, M. Et Al. (2020) . "Treatment of high-grade non-muscle invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations: Results of the phase III clinical trial (NIMBUS)." Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO) , San-Francisco, Costa Rica.
@conferencepaper{conferencepaper, author={Marc-Oliver Grimm Et Al. }, title={Treatment of high-grade non-muscle invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations: Results of the phase III clinical trial (NIMBUS)}, congress name={Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO)}, city={San-Francisco}, country={Costa Rica}, year={2020}}